Methods for isolating spider silk proteins via high shear solubilization

US2022372086A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2022372086-A1
Application numberUS-202017636721-A
CountryUS
Kind codeA1
Filing dateSep 16, 2020
Priority dateSep 16, 2019
Publication dateNov 24, 2022
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to methods of isolating and purifying synthetic block copolymer proteins via the application of solvents and high shear microfluidization methods.

First claim

Opening claim text (preview).

1 . A method of isolating a recombinant spider silk protein from a host cell, comprising: a. providing an insoluble mass comprising a recombinant spider silk protein; b. adding the insoluble mass to an aqueous solution comprising a solvent; and c. applying a shear force to the aqueous solution comprising the insoluble mass thereby solubilizing the recombinant spider silk protein in the aqueous solution. 2 . The method of claim 1 , wherein the shear force is applied via microfluidization. 3 . The method of claim 2 , wherein the microfluidization generates shear rates of about 6×10 6 s −1 to 10×10 6 s −1 . 4 .- 5 . (canceled) 6 . The method of claim 2 , wherein the microfluidization is performed at between 20,000 psi to 30,000 psi. 7 .- 8 . (canceled) 9 . The method of claim 2 , wherein the microfluidizer an M-110P or an LM10 microfluidizer. 10 .- 11 . (canceled) 12 . The method of claim 1 , wherein the shear force is applied at least twice. 13 .- 15 . (canceled) 16 . The method of claim 1 , wherein the insoluble mass is derived from a cell culture comprising a host cell, wherein the host cell expresses the recombinant spider silk protein, and the method further comprises collecting the insoluble mass derived from the cell culture. 17 . (canceled) 18 . The method of claim 1 , wherein the solvent is a chaotropic agent. 19 . The method of claim 18 , wherein the chaotropic agent is urea, guanidine thiocyanate (GdnSCN), or guanidine chloride (GdnHCL). 20 . The method of claim 1 , wherein the insoluble mass is added to the aqueous solution at about a 5%, 10%, 15%, 20%, 25%, or 30% insoluble mass to solvent volume. 21 . The method of claim 19 , wherein the chaotropic agent is present in the aqueous solution at a concentration from 0.1-10M. 22 . The method of claim 19 , wherein the aqueous solution comprises about 10M urea, about 4M-8M GdnHCl, or about 3M-6M GdnSCN. 23 .- 24 . (canceled) 25 . The method of claim 20 , wherein the aqueous solution comprises about a 15% insoluble portion mass to an 85% volume of 3M GdnSCN. 26 . The method of claim 20 , wherein the aqueous solution comprises about a 15% insoluble portion mass to an 85% volume of 4M GdnHCI. 27 . The method of claim 20 , wherein the aqueous solution comprises about a 15% insoluble portion mass to an 85% volume of 10M urea. 28 . The method of claim 1 , wherein the insoluble mass is incubated between 20° C. and 30° C. 29 .- 30 . (canceled) 31 . The method of claim 1 , wherein the insoluble portion is incubated in the aqueous solution comprising the solvent for 60 to 120 minutes. 32 .- 35 . (canceled) 36 . The method of claim 1 , wherein the insoluble mass comprises a cell pellet, and method further comprises: a. incubating the cell pellet with a solution comprising 4M urea at a 10:1 urea volume to pellet mass ratio; and b. centrifuging the solution comprising 4M urea to obtain a second cell pellet prior to incubating the second cell pellet in the aqueous solution comprising a solvent. 37 . The method of claim 1 , further comprising isolating the recombinant spider silk protein from the aqueous solution, thereby producing an isolated recombinant spider silk protein. 38 . The method of claim 1 , wherein the recombinant spider silk protein is a highly crystalline silk protein, a high beta sheet content silk protein, or a low solubility silk protein. 39 . The method of claim 38 , wherein the recombinant spider silk protein comprises the Uloborus diversus MiSP protein as set forth in SEQ ID NO: 23. 40 . The method of claim 38 , wherein the recombinant spider silk protein has a solubility threshold of less than 90%, 80%, 70%, 60%, or 50% in a non-chaotropic solvent. 41 . (canceled) 42 . The method of claim 1 , wherein the cell is Escherichia coli. 43 .- 44 . (canceled) 45 . The method of claim 1 , wherein the isolated recombinant spider silk protein is full-length recombinant spider silk protein. 46 .- 48 . (canceled) 49 . The method of claim 1 , wherein the purity of the isolated recombinant spider silk protein is 5-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 45-50%, 50-55%, 55-60%, 60-65%, 65-70%, 70-75%, 75-80%, 80-85%, 85-90%, 09-95%, or 95-100%. 50 . A method of isolating a recombinant spider silk protein from a host cell, comprising: a. providing an insoluble mass comprising a recombinant spider silk protein; b. adding the insoluble mass to an aqueous solution comprising a solvent, wherein the aqueous solution comprises 15% (w/v) insoluble portion in a final 10M urea concentration; c. applying a shear force via microfluidization to the aqueous solution comprising the insoluble mass thereby solubilizing the recombinant spider silk protein in the aqueous solution; and d. isolating the recombinant spider silk protein from the aqueous solution, thereby producing an isolated recombinant spider silk protein. 51 . A method of isolating a recombinant spider silk protein from a host cell, comprising: a. providing an insoluble mass comprising a recombinant spider silk protein; b. adding the insoluble mass to an aqueous solution, wherein the aqueous solution comprises about a 15% (w/v) insoluble portion in a final 10M urea concentration; c. applying a shear force via microfluidization, wherein the shear force is about 10×10 6 s −1 , to the aqueous solution thereby solubilizing the recombinant spider silk protein in the aqueous solution; and d. isolating the recombinant spider silk protein from the aqueous solution, thereby producing an isolated recombinant spider silk protein. 52 . A composition comprising a recombinant spider silk protein produced by the method of claim 1 . 53 . (canceled) 54 . A silk fiber comprising a recombinant spider silk protein produced by the method of claim 1 .

Assignees

Inventors

Classifications

  • Silk · CPC title

  • from spiders · CPC title

  • Monocomponent artificial filaments or the like of proteins; Manufacture thereof · CPC title

  • containing ingredients of undetermined constitution or reaction products thereof {, e.g. transplant tissue, natural bone, extracellular matrix (isolated natural compounds, e.g. collagen A61L27/24)} · CPC title

  • containing a His-tag · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2022372086A1 cover?
The present disclosure relates to methods of isolating and purifying synthetic block copolymer proteins via the application of solvents and high shear microfluidization methods.
Who is the assignee on this patent?
Bolt Threads Inc
What technology area does this patent fall under?
Primary CPC classification C07K14/43518. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Nov 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).